Adjuvant Oxaliplatin Confers Survival Benefit in Colon Ca (CME/CE)

(MedPage Today) — Among community-based colon cancer patients, the addition of oxaliplatin to 5-fluorouracil (5-FU) in the adjuvant treatment setting may offer better survival, according to a retrospective analysis.

Post a Comment

Comments are closed.